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LETTERS
The role of steroids in treating 
patients with S. suis infection remains 
unclear, although this case illustrates 
that the inﬂ  ammation associated with 
this infection can be profound and 
can require prolonged steroid therapy. 
Since at least 2 cases of relapse have 
been reported after 2 and 4 weeks 
of treatment (1), prolonged therapy 
should be considered for infections 
caused by this pathogen. Hearing loss 
from  S. suis meningitis occurs fre-
quently and can be irreversible (1). 
Hawaii’s swine industry is character-
ized by small herds and a high degree 
of concentration (9). This case of 
human S. suis meningitis in Hawaii 
emphasizes the need for these data 
to be generated and made available. 
Indeed, this bacterium is increasingly 
recognized as a signiﬁ  cant zoonotic 
agent in Asia; although it remains a 
relatively rare cause of human infec-
tion elsewhere, persons in close oc-
cupational contact with pigs or pork 
products are at higher risk than others 
(1). Increasing awareness of this dis-
ease is expected to help counter hu-
man S. suis infections.
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Chorioamnionitis 
and Neonatal 
Sepsis from 
Community-
associated MRSA
To the Editor: Chorioamnionitis 
is a common cause of maternal and 
neonatal illness and death (1), but cho-
rioamnionitis attributed to Staphylo-
coccus aureus, including methicillin-
resistant S. aureus (MRSA), is reported 
infrequently (2–5). In the context of 
the rising incidence of community-
associated MRSA (CA-MRSA) infec-
tions (6), we report an apparent case of 
CA-MRSA chorioamnionitis.
The patient, a 31-year-old woman 
with polycystic ovary syndrome and 
hypothyroidism, had 1 prior preg-
nancy but no viable offspring. After a 
clomiphene-assisted conception, rou-
tine ultrasound at 21 weeks’ gestation 
identiﬁ  ed a shortened cervix (5 mm). 
The patient declined amniocentesis 
for cerclage and was treated with pel-
vic rest and vaginal progesterone. Five 
days later, she arrived at the emergency 
department with foul-smelling vaginal 
discharge. At this time, the patient was 
afebrile and hemodynamically stable, 
had no abdominal pain, and had a leu-
kocyte count of 9.5 × 103 cells/mm3.
Premature rupture of membranes 
was diagnosed, and the patient was 
admitted and administered intrave-
nous ampicillin and azithromycin. 
Nine days into treatment, at 23 weeks’ 
gestation, 210 hours after membrane 
rupture, a 415-g live-born girl was 
delivered spontaneously in footling 
breech with Apgar scores of 1 (1 min) 
and 5 (5 min). During admission, the 
mother was never febrile and did not 
complain of abdominal tenderness or 
chills. The highest leukocyte count 
was 12.4 × 103 cells/mm3. The mother 
was discharged the day after deliv-
ery without further complications. At 
6-week follow-up, she remained well, 
with no signs of infection.
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Pathologic examination of the pla-
centa demonstrated focal acute funisi-
tis, acute chorioamnionitis with fetal 
surface acute arteritis and acute deci-
duitis. Cultures from the maternal and 
fetal sides of the placenta grew pre-
dominantly MRSA and rare colonies 
of methicillin-susceptible S. aureus. 
The MRSA antimicrobial drug proﬁ  le, 
including trimethoprim/sulfamethox-
azole and clindamycin susceptibility, 
was characteristic of CA-MRSA (6).
The neonate, who died on day 16, 
was culture-positive for CA-MRSA 
from blood, 2 umbilical swabs, and 
a tracheal aspirate. The antibiogram 
of these isolates was identical to the 
placental cultures, including absence 
of inducible clindamycin resistance. 
Postmortem examination showed 
hemorrhagic necrotizing pneumonia 
and gram-negative bacilli. Culture 
of lung tissue grew Escherichia coli. 
Isolates from the placenta and neonate 
were identiﬁ  ed phenotypically, with-
out molecular testing.
Maternal complications of cho-
rioamnionitis include endometritis, 
bacteremia, hemorrhage, and cesarean 
delivery (1). Clinically, chorioamni-
onitis can be diagnosed by maternal 
fever (>38oC) and 2 of the following: 
maternal leukocytosis (>15 × 103cells/
mm3), maternal tachycardia (>100 
bpm), fetal tachycardia (>160 bpm), 
uterine tenderness, and foul-smelling 
amniotic  ﬂ  uid  (1). This patient had 
none of these signs, except foul-smell-
ing amniotic ﬂ  uid, and fetal tachycar-
dia was absent. In this case, chorioam-
nionitis was diagnosed by histology.
Amniotic  ﬂ   uid cultures from 
pregnancies complicated by chorio-
amnionitis have shown multiple or-
ganisms from the vaginal ﬂ  ora, such 
as Streptococcus agalactiae, Gardner-
ella vaginalis, Mycoplasma hominis, 
Ureaplasma urealyticum, anaerobes, 
and E. coli (1). Chorioamnionitis as-
sociated with S. aureus is uncommon 
(2,3), and MRSA chorioamnionitis is 
rare (4,5). The ﬁ  rst 2 reports of MRSA 
chorioamnionitis appeared in 1998 
(4) and 2002 (5). In both instances, 
the patients worked in the healthcare 
industry, and the authors considered 
the MRSA to have been nosocomial 
strains. The patient in our report was 
a restaurant manager, had no prior re-
corded hospital admissions, and was 
not previously known to be colonized 
by MRSA.
CA-MRSA strains are epide-
miologically and clonally unrelated 
to hospital-associated MRSA (HA-
MRSA) strains and can be differ-
entiated by the presence of staphy-
lococcal cassette chromosome mec 
type IV and the absence of multidrug 
resistance seen with HA-MRSA (6). 
Recently, the incidence of CA-MR-
SA infections increased in commu-
nity settings, including outbreaks in 
settings in which CA-MRSA is en-
demic, with manifestations ranging 
from skin and soft tissue infections 
to necrotizing pneumonia (6). Geni-
tal colonization with MRSA recently 
has been reported with a frequency of 
0.5%–3.5% in pregnant women (7,8). 
In 1 study, most (93%) of these iso-
lates were CA-MRSA (7).
Eckhardt et al. described a pa-
tient with chorioamnionitis in whom 
CA-MRSA bacteremia developed (9). 
However, this descriptor was used to 
specify multidrug-resistant MRSA 
not acquired in a hospital. Moreover, 
neither placental nor amniotic ﬂ  uid 
cultures were described. Laibl et al. 
reported 2 patients with CA-MRSA 
infections in whom chorioamnionitis 
developed (10). Again, placental and 
amniotic  ﬂ   uid culture results were 
not reported, nor was chorioamni-
onitis listed as an infection caused by 
CA-MRSA in their cohort. However, 
these latter 2 patients might repre-
sent additional cases of CA-MRSA 
chorioamnionitis.
Although the incidence of CA-
MRSA infections continues to in-
crease, CA-MRSA chorioamnionitis 
appears to remain rare. Nevertheless, 
the prevalence of MRSA genital colo-
nization among pregnant women cre-
ates an opportunity for this agent to 
cause ascending gestational infection. 
This  ﬁ   nding is meaningful because 
recommended empirical antimicro-
bial drug treatments may not cover 
CA-MRSA, increasing the likelihood 
of infectious complications (1). How-
ever, culture results when available 
can provide therapeutic guidance. 
We hope this report raises awareness 
of the possibility of CA-MRSA cho-
rioamnionitis and encourages reports 
from other authors so this entity can 
be better established, characterized, 
and monitored.
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Methicillin-
Resistant 
Staphylococcus 
aureus in Marine 
Mammals 
To the Editor: Methicillin-resis-
tant  Staphylococcus aureus (MRSA) 
is emerging as an important cause of 
illness and death in animals and has 
been found in an impressive variety 
of species. However, to date, only 2 
studies have reported the isolation of 
MRSA from marine mammals, 1 seal 
(1) and 3 bottlenose dolphins (2). We 
describe an investigation that was con-
ducted after MRSA was isolated from 
a dolphin at a marine park in North 
America.
In November 2006, a 20-year-
old, male, captive, bottlenose dolphin, 
suspected of having pneumonia, was 
treated empirically with ciproﬂ  oxacin 
and itraconazole. Despite treatment, 
the dolphin died in December 2006. A 
necropsy was performed, and a culture 
swab specimen of the blowhole was 
submitted for bacteriologic examina-
tion; MRSA was then isolated. The 
clinical relevance of this ﬁ  nding was 
unclear. Pulsed-ﬁ   eld gel electropho-
resis (PFGE) was conducted (3), and 
results indicated that the MRSA strain 
isolated was the Canadian epidemic 
MRSA (CMRSA)2 (USA100) strain, 
the predominant hospital- and com-
munity-associated MRSA strain found 
in persons in Canada (4). To determine 
the extent of MRSA colonization in 
this marine park, blowhole swab spec-
imens were collected from dolphins, 
orcas, and beluga whales, and nasal 
swab specimens were collected from 
walruses, sea lions, harbor seals, gray 
seals, and park personnel, excluding 4 
employees in January 2007. Selective 
culture for MRSA was performed, and 
strains were typed with PFGE (3) and 
spa typing (5). All MRSA strains were 
investigated for the Panton-Valentine 
leukocidin (PVL) toxin genes (6).
In January 2007, MRSA was not 
isolated from personnel (0/22), sea 
lions (0/12), harbor seals (0/2), gray 
seals (0/2), orcas (0/4), or beluga 
whales (0/23); it was isolated from dol-
phins (2/6, 33.3%) and a walrus (1/6, 
16.7%). To reduce the risk for MRSA 
transmission among the marine mam-
mals and to personnel, the following 
steps were recommended: colonized 
animals were isolated, contact with 
colonized animals was restricted, all 
park personnel were required to wear 
gloves and masks when handling 
colonized animals, and routine hand 
hygiene was emphasized. Colonized 
walruses were isolated in a separate 
facility until May 2007. Because of 
space limitations, colonized dolphins 
could not be isolated. Although the 
park instituted a strict policy that re-
quired personnel to wear gloves and 
masks, this policy ceased during the 
summer months due to the park’s ex-
hibition schedule.
Because we knew from our ob-
servations of other animal species that 
natural decolonization with MRSA is 
common, as well as lacking informa-
tion about antimicrobial drug efﬁ  cacy 
for MRSA decolonization in marine 
mammals, and had concerns regarding 
the emergence of further antimicrobial 
drug resistance, we recommended that 
no attempt be made to decolonize the 
animals with antimicrobial agents. Af-
ter these recommendations were made 
and implemented, follow-up testing 
for MRSA colonization was performed 
on the dolphins and walruses through-
out 2007 and 2008 (Table). In Octo-
ber 2007, testing conducted on all sea 
lions, harbor seals, gray seals, orcas, 
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Table. MRSA colonization status of dolphins and walruses during 2007–2008* 
Date
No. (%) dolphins MRSA 
positive
Identification nos. of 
MRSA-positive dolphins 
No. (%) walruses MRSA 
positive
Identification nos. of 
MRSA-positive walruses 
2007 Jan  2/6 (33.3)  2, 3  1/6 (16.7)  1
2007 Feb  2/6 (33.3)  2, 4  2/5 (40)  2, 3 
2007 Apr  2/5† (40)  3, 5  0/6 (0)  NA
2007 May  2/3 (66.7)  3, 5  0/6 NA
2007 Oct  1/5 (20)  3 0/5 NA
2008 May  1/5 (20)  3 NT NA
2008 Jul  0/5 NA NT NA
2008 Oct  0/5 NA NT NA
*MRSA, methicillin-resistant Staphylococcus aureus; NA, not applicable; NT, not tested. 
†Dolphin 2 died due to unknown circumstances. 